| Genetic Selection of Peptide Inhibitors of Biological Pathways.
Science 285:591-595 (1999).
(Note: Current Rosetta Inpharmatics employees are shown in boldface
type.)
T. C. Norman, D. L. Smith, P. K. Sorger, B. L. Drees, S. M. O'Rourke,
Timothy R. Hughes, Christopher J. Roberts, Stephen H.
Friend, S. Fields, and A. W. Murray.
Abstract
Genetic selections were used to find peptides that inhibit biological
pathways in budding yeast. The peptides were presented inside cells
as peptamers, surface loops on a highly expressed and biologically
inert carrier protein, a catalytically inactive derivative of staphylococcal
nuclease. Peptamers that inhibited the pheromone signaling pathway,
transcriptional silencing, and the spindle checkpoint were isolated.
Putative targets for the inhibitors were identified by a combination
of two-hybrid analysis and genetic dissection of the target pathways.
This analysis identified Ydr517w as a component of the spindle checkpoint
and reinforced earlier indications that Ste50 has both positive
and negative roles in pheromone signaling. Analysis of transcript
arrays showed that the peptamers were highly specific in their effects,
which suggests that they may be useful reagents in organisms that
lack sophisticated genetics as well as for identifying components
of existing biological pathways that are potential targets for drug
discovery.
Science is available online
|